GSK heart drug disappoints in study, shingles vaccine on track
October 27, 2015 at 07:14 AM EDT
LONDON, Oct 27 (Reuters) - An experimental heart drug from GlaxoSmithKline called losmapimod failed to work as hoped in the first part of a large clinical trial, the company said on Tuesday, dealing a blow to its pipeline of new medicines.